Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmacol Ther. 2014 Jun;142(3):416-35. doi: 10.1016/j.pharmthera.2014.01.004. Epub 2014 Jan 31.

Targeting mast cells in inflammatory diseases.

Author information

1
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: lreber@stanford.edu.
2
Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS-Université de Strasbourg, Faculté de Pharmacie, France.

Abstract

Although mast cells have long been known to play a critical role in anaphylaxis and other allergic diseases, they also participate in some innate immune responses and may even have some protective functions. Data from the study of mast cell-deficient mice have facilitated our understanding of some of the molecular mechanisms driving mast cell functions during both innate and adaptive immune responses. This review presents an overview of the biology of mast cells and their potential involvement in various inflammatory diseases. We then discuss some of the current pharmacological approaches used to target mast cells and their products in several diseases associated with mast cell activation.

KEYWORDS:

FcεRI; IgE; Mast cells; Stem cell factor (SCF); c-KIT

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center